Join
Live feed
·
PRReleasevia Quantisnow
OmniAb Inc. logo

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

ByQuantisnow·Wall Street's wire, on your screen.
OABI· OmniAb Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OABI (OmniAb Inc.) and more on Quantisnow.